Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Karyopharm Therapeutics Company Profile (NASDAQ:KPTI)

Consensus Ratings for Karyopharm Therapeutics (NASDAQ:KPTI) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $53.80 (96.49% upside)

Analysts' Ratings History for Karyopharm Therapeutics (NASDAQ:KPTI)
Show:
DateFirmActionRatingPrice TargetActions
5/23/2015Leerink SwannReiterated RatingOutperform$60.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Leerink SwannLower Price TargetOutperform$60.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015OppenheimerReiterated RatingOutperform$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015MLV & Co.Reiterated RatingBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014OppenheimerUpgradeMarket Perform -> Outperform$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Barrington ResearchInitiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014MLV & Co.Initiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014WedbushInitiated CoverageOutperform$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Leerink SwannLower Price Target$63.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2014OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2014RBC CapitalLower Price TargetView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014JMP SecuritiesBoost Price TargetOutperform$25.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014Bank of AmericaBoost Price TargetBuy$40.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013JMP SecuritiesInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013Bank of AmericaInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013OppenheimerInitiated CoverageOutperform$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2013 forward)